Patent · US Active

Prodrugs and drug-macromolecule conjugates having controlled drug release rates

US9387254B2 · kind B2 · utility

9Cited by

3References

7Claims

0Family size

Assignee

PROLYNX LLC · US

Inventors

Daniel V. Santi · San Francisco, US
Gary Ashley · Alameda, US

Key dates

Filing date	Mar 21, 2014
Grant date	Jul 12, 2016
Priority date	—
Expiry date	Apr 26, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08L2203/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides methods and compositions that permit controlled and prolonged drug release in vivo. The compounds are either prodrugs with tunable rates of release, or conjugates of the drug with macromolecules which exhibit tunable controlled rates of release.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.